MILLENNIUM MANAGEMENT LLC

Position in DNA — Ginkgo Bioworks Holdings, Inc.

CIK 1273087 NEW YORK, NY

Back to DNA Full portfolio

Position in DNA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,329,279

+$3,338,103 QoQ

Shares Held

638,676

+30.9% QoQ

Ownership

0.948%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#13

of 183 holders

Holding Since

Sep 2021

20 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in DNA Over Time

Shares Held

Position Value (USD)

Derivatives in DNA

reported options exposure · as of Jun 30, 2024

CallValue

CallShares

371,419

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MILLENNIUM MANAGEMENT LLC holds $4,596,585,112 across 322 Biotechnology names. DNA ranks #150 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	468,410	$232,673,299
2	INSM	INSMED Inc	2,048,005	$218,358,293
3	APGE	Apogee Therapeutics, Inc.	1,491,404	$197,954,052
4	JAZZ	Jazz Pharmaceuticals plc	763,880	$184,072,163
5	ONC	BeOne Medicines Ltd.	543,323	$154,830,755
6	AXSM	Axsome Therapeutics, Inc.	556,088	$136,113,659
7	BMRN	Biomarin Pharmaceutical Inc	2,071,816	$118,549,311
8	REGN	Regeneron Pharmaceuticals, Inc.	165,120	$102,958,924

All Filings in DNA

Export CSV

38 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,329,279	638,676	+30.9%	Shares	Sole	2026-08-14
2026-03-31	$2,991,176	487,957	+897.8%	Shares	Sole	2026-05-15
2025-12-31	$406,367	48,901	+113.9%	Shares	Sole	2026-02-17
2025-09-30	$333,357	22,864	-98.3%	Shares	Sole	2025-11-14
2025-06-30	$15,239,441	1,354,617	-5.1%	Shares	Sole	2025-08-14
2025-03-31	$8,137,320	1,427,600	+113.1%	Shares	Sole	2025-05-15
2024-12-31	$6,580,038	670,065	+357.4%	Shares	Sole	2025-02-14
2024-09-30	$1,193,926	146,494	-93.3%	Shares	Sole	2024-11-14
2024-06-30 DNABW	—	371,419	-1.9%	Call	Sole	2024-08-14
2024-06-30	$728,087	2,179,904	-79.4%	Shares	Sole	2024-08-14
2024-03-31 DNABW	—	378,619	0.0%	Call	Sole	2024-05-15
2024-03-31	$12,267,117	10,575,101	+14.1%	Shares	Sole	2024-05-15
2023-12-31 DNABW	—	378,619	0.0%	Call	Sole	2024-02-14
2023-12-31	$15,660,222	9,266,404	+0.0%	Shares	Sole	2024-02-14
2023-12-31	$507,000	300,000	+50.0%	Put	Sole	2024-02-14
2023-09-30 DNABW	—	378,619	-23.5%	Call	Sole	2023-11-14
2023-09-30	$16,767,045	9,263,561	+27.2%	Shares	Sole	2023-11-14
2023-09-30	$1,538,500	850,000	+70.0%	Call	Sole	2023-11-14
2023-06-30 DNABW	—	494,762	0.0%	Call	Sole	2023-08-14
2023-06-30	$13,541,916	7,280,600	+6536.2%	Shares	Sole	2023-08-14
2023-03-31 DNABW	—	494,762	-1.3%	Call	Sole	2023-05-15
2023-03-31	$665,000	500,000	0.0%	Call	Sole	2023-05-15
2022-12-31 DNABW	—	501,360	-0.4%	Call	Sole	2023-02-14
2022-12-31	$845,000	500,000	-45.7%	Call	Sole	2023-02-14
2022-09-30 DNABW	—	503,160	0.0%	Call	Sole	2022-11-14
2022-09-30	$624,000	200,000	—	Put	Sole	2022-11-14
2022-09-30	$342,295	109,710	-96.4%	Shares	Sole	2022-11-14
2022-09-30	$2,870,400	920,000	+130.0%	Call	Sole	2022-11-14
2022-06-30 DNABW	—	503,160	+18.1%	Call	Sole	2022-08-15
2022-06-30	$7,280,398	3,058,991	+40.8%	Shares	Sole	2022-08-15
2022-03-31 DNABW	—	426,099	-2.3%	Call	Sole	2022-05-16
2022-03-31	$1,612,000	400,000	+33.3%	Call	Sole	2022-05-16
2022-03-31	$8,756,557	2,172,843	+245.0%	Shares	Sole	2022-05-16
2021-12-31 DNABW	—	436,015	-1.4%	Call	Sole	2022-02-14
2021-12-31	$2,493,000	300,000	—	Call	Sole	2022-02-14
2021-12-31	$5,234,444	629,897	-58.3%	Shares	Sole	2022-02-14
2021-09-30 DNABW	—	442,015	—	Call	Sole	2021-11-15
2021-09-30	$17,517,809	1,511,459	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.